| 000 | 04886naaaa2201489uu 4500 | ||
|---|---|---|---|
| 001 | https://directory.doabooks.org/handle/20.500.12854/58295 | ||
| 005 | 20220714164358.0 | ||
| 020 | _abooks978-3-03897-066-8 | ||
| 020 | _a9783038970651 | ||
| 020 | _a9783038970668 | ||
| 024 | 7 |
_a10.3390/books978-3-03897-066-8 _cdoi |
|
| 041 | 0 | _aEnglish | |
| 042 | _adc | ||
| 100 | 1 |
_aTang, Chih-Hsin _4auth _91579871 |
|
| 245 | 1 | 0 | _aResearch of Pathogenesis and Novel Therapeutics in Arthritis |
| 260 |
_bMDPI - Multidisciplinary Digital Publishing Institute _c2019 |
||
| 300 | _a1 electronic resource (366 p.) | ||
| 506 | 0 |
_aOpen Access _2star _fUnrestricted online access |
|
| 520 | _aArthritis has a high prevalence globally and includes over 100 different types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for arthritis patients. This book summarizes and discusses the global picture of the current understanding of arthritis. | ||
| 540 |
_aCreative Commons _fhttps://creativecommons.org/licenses/by-nc-nd/4.0/ _2cc _4https://creativecommons.org/licenses/by-nc-nd/4.0/ |
||
| 546 | _aEnglish | ||
| 653 | _areceptor activator of nuclear factor ?B | ||
| 653 | _ainfliximab | ||
| 653 | _atripterine | ||
| 653 | _atriptolide | ||
| 653 | _aosteoblast | ||
| 653 | _atumor necrosis factor-alpha | ||
| 653 | _asynovial cell | ||
| 653 | _aanti-arthritis | ||
| 653 | _abiosimilars | ||
| 653 | _aEpstein-Barr virus | ||
| 653 | _acytokines | ||
| 653 | _aSOX9 | ||
| 653 | _aparathyroid hormone | ||
| 653 | _anitric oxide | ||
| 653 | _arat | ||
| 653 | _aetanercept | ||
| 653 | _aangiogenesis | ||
| 653 | _aglycosylation | ||
| 653 | _amitogen activated protein kinase | ||
| 653 | _aTh9 lymphocytes | ||
| 653 | _arheumatoid arthritis | ||
| 653 | _aIL-6 | ||
| 653 | _aclodronate | ||
| 653 | _abone erosion | ||
| 653 | _amesenchymal stem cells | ||
| 653 | _acollagen-induced arthritis | ||
| 653 | _abiological | ||
| 653 | _agene expression | ||
| 653 | _ainflammatory arthritis | ||
| 653 | _aosteoarthritis | ||
| 653 | _afraxinellone | ||
| 653 | _anuclear factor kappa B | ||
| 653 | _amessenger RNA | ||
| 653 | _ainflammation | ||
| 653 | _amiRNA | ||
| 653 | _adisease-modifying | ||
| 653 | _aadipokines | ||
| 653 | _aWNT | ||
| 653 | _aglycoprotein 42 | ||
| 653 | _amiR-199a-5p | ||
| 653 | _aproliferation | ||
| 653 | _anext-generation sequencing | ||
| 653 | _acollagen | ||
| 653 | _aosteoarthritis (OA) | ||
| 653 | _aexperimental arthritis | ||
| 653 | _abone morphogenetic protein | ||
| 653 | _aTNF-? | ||
| 653 | _acomputational modeling | ||
| 653 | _abasic research | ||
| 653 | _aosteoclast | ||
| 653 | _atherapeutics | ||
| 653 | _acertolizumab pegol | ||
| 653 | _achondrocytes | ||
| 653 | _aprogenitor cells | ||
| 653 | _aadjuvant arthritis | ||
| 653 | _aadalimumab | ||
| 653 | _atriterpenoid | ||
| 653 | _asclareol | ||
| 653 | _aTNF? | ||
| 653 | _afibroblast growth factor 2 | ||
| 653 | _aantibodies | ||
| 653 | _aosteoblasts | ||
| 653 | _amolecular pathology | ||
| 653 | _aTh17 | ||
| 653 | _aimmunology | ||
| 653 | _aobesity | ||
| 653 | _avisfatin | ||
| 653 | _aarticular cartilage | ||
| 653 | _aautoimmune | ||
| 653 | _abiomarkers | ||
| 653 | _acelastrol | ||
| 653 | _aMAPK | ||
| 653 | _adisease pathways | ||
| 653 | _aIL1? | ||
| 653 | _aarthritis | ||
| 653 | _abioinformatics | ||
| 653 | _aanticitrullinated peptide antibodies | ||
| 653 | _adrug delivery system | ||
| 653 | _aantagonists | ||
| 653 | _ashared epitope | ||
| 653 | _apathology | ||
| 653 | _aSMA- and MAD-related protein | ||
| 653 | _asmall-molecule inhibitor | ||
| 653 | _atransforming growth factor ? | ||
| 653 | _amice | ||
| 653 | _agolimumab | ||
| 653 | _aspinal fusion | ||
| 653 | _aantirheumatic drug | ||
| 653 | _aearly osteoarthritis | ||
| 653 | _astem cell | ||
| 653 | _arheumatoid factor | ||
| 653 | _atherapeutic antibody | ||
| 653 | _abisphosphonate | ||
| 653 | _aosteoclastogenesis | ||
| 653 | _ainterleukin | ||
| 653 | _aspondyloarthropathies | ||
| 653 | _aclinical translation | ||
| 653 | _atherapy | ||
| 653 | _aTraditional Chinese medicine | ||
| 653 | _achemokines | ||
| 653 | _astructure | ||
| 653 | _acell signaling | ||
| 653 | _amicroRNA | ||
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://mdpi.com/books/pdfview/book/1327 _70 _zDOAB: download the publication |
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://directory.doabooks.org/handle/20.500.12854/58295 _70 _zDOAB: description of the publication |
| 999 |
_c2985032 _d2985032 |
||